publication . Other literature type . Article . 2019

Identification of kif11 as a novel target in meningioma

Andreas von Deimling; Mario Loehr; Andreas Unterberg; Steffen Dettling; Juergen Debus; Carmen Rapp; Mahmoud Moustafa; Christel Herold-Mende; Christian Senft; Christine Jungk; ...
Open Access English
  • Published: 01 Apr 2019 Journal: Cancers (issn: 2072-6694, Copyright policy)
  • Publisher: Multidisciplinary Digital Publishing Institute
Abstract
I n = 61, WHO&deg
Subjects
Medical Subject Headings: macromolecular substances
free text keywords: meningioma, KIF, kinesin, KIF11, NCH93, Article, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Cancer Research, Oncology, KIF4A, Gene knockdown, Microarray, Downregulation and upregulation, Intracellular vesicle, Biology, KIFC1, Immunohistochemistry, medicine.disease, medicine
Download fromView all 4 versions
Cancers
Article . 2019
Cancers
Article . 2019
Provider: Crossref
88 references, page 1 of 6

Mawrin, C., Perry, A.. Pathological classification and molecular genetics of meningiomas. J. Neurooncol.. 2010; 99: 379-391 [OpenAIRE] [PubMed] [DOI]

Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W., Kleihues, P.. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol.. 2007; 114: 97-109 [OpenAIRE] [PubMed] [DOI]

Baldi, I., Engelhardt, J., Bonnet, C., Bauchet, L., Berteaud, E., Gruber, A., Loiseau, H.. Epidemiology of meningiomas. Neurochirurgie. 2014 [OpenAIRE] [PubMed] [DOI]

Van Alkemade, H., de Leau, M., Dieleman, E.M., Kardaun, J.W., van Os, R., Vandertop, W.P., van Furth, W.R., Stalpers, L.J.. Impaired survival and long-term neurological problems in benign meningioma. Neuro Oncol.. 2012; 14: 658-666 [OpenAIRE] [PubMed] [DOI]

Durand, A., Labrousse, F., Jouvet, A., Bauchet, L., Kalamarides, M., Menei, P., Deruty, R., Moreau, J.J., Fevre-Montange, M., Guyotat, J.. WHO grade II and III meningiomas: A study of prognostic factors. J. Neuro Oncol.. 2009; 95: 367-375 [OpenAIRE] [PubMed] [DOI]

Vranic, A., Popovic, M., Cor, A., Prestor, B., Pizem, J.. Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: A study of 86 patients. Neurosurgery. 2010; 67: 1124-1132 [OpenAIRE] [PubMed] [DOI]

Gousias, K., Schramm, J., Simon, M.. The Simpson grading revisited: Aggressive surgery and its place in modern meningioma management. J. Neurosurg.. 2016; 125: 551-560 [OpenAIRE] [PubMed] [DOI]

Alexiou, G.A., Gogou, P., Markoula, S., Kyritsis, A.P.. Management of meningiomas. Clin. Neurol Neurosurg.. 2010; 112: 177-182 [OpenAIRE] [PubMed] [DOI]

Clark, V.E., Erson-Omay, E.Z., Serin, A., Yin, J., Cotney, J., Ozduman, K., Avsar, T., Li, J., Murray, P.B., Henegariu, O., Yilmaz, S.. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013; 339: 1077-1080 [OpenAIRE] [PubMed] [DOI]

Clark, V.E., Harmanci, A.S., Bai, H., Youngblood, M.W., Lee, T.I., Baranoski, J.F., Ercan-Sencicek, A.G., Abraham, B.J., Weintraub, A.S., Hnisz, D.. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat. Genet.. 2016; 48: 1253-1259 [OpenAIRE] [PubMed] [DOI]

Abedalthagafi, M., Bi, W.L., Aizer, A.A., Merrill, P.H., Brewster, R., Agarwalla, P.K., Listewnik, M.L., Dias-Santagata, D., Thorner, A.R., Van Hummelen, P.. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol.. 2016; 18: 649-655 [OpenAIRE] [PubMed] [DOI]

Brastianos, P.K., Horowitz, P.M., Santagata, S., Jones, R.T., McKenna, A., Getz, G., Ligon, K.L., Palescandolo, E., Van Hummelen, P., Ducar, M.D.. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat. Genet.. 2013; 45: 285-289 [OpenAIRE] [PubMed] [DOI]

Sahm, F., Schrimpf, D., Olar, A., Koelsche, C., Reuss, D., Bissel, J., Kratz, A., Capper, D., Schefzyk, S., Hielscher, T.. TERT promoter mutations and risk of recurrence in meningioma. J. Natl. Cancer Inst.. 2016: 108 [OpenAIRE] [PubMed] [DOI]

Reuss, D.E., Piro, R.M., Jones, D.T., Simon, M., Ketter, R., Kool, M., Becker, A., Sahm, F., Pusch, S., Meyer, J.. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol.. 2013; 125: 351-358 [OpenAIRE] [PubMed] [DOI]

Pachow, D., Andrae, N., Kliese, N., Angenstein, F., Stork, O., Wilisch-Neumann, A., Kirches, E., Mawrin, C.. mTORC1 inhibitors suppress meningioma growth in mouse models. Clin. Cancer Res.. 2013; 19: 1180-1189 [OpenAIRE] [PubMed] [DOI]

88 references, page 1 of 6
Any information missing or wrong?Report an Issue